Basic Information
LncRNA/CircRNA Name | PRINS |
Synonyms | PRINS, NCRNA00074 |
Region | GRCh38_1:29554-31109 |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, RNAi, Western blot, Luciferase reporter assay, FISH etc. |
Sample | cell line (HT-29) |
Expression Pattern | differential expression |
Function Description | RNA interference-based gain- and loss-of-function experiments examined miR-491-PRINS axis to exert the TFF3-mediated phenotype. Chemical inhibition of selected pathways showed that phosphatidylinositol 3-kinase/AKT accounts for TFF3-mediated downregulation of miR-491-5p and accumulation of PRINS. Moreover, we showed that PRINS colocalises with PMAIP1 (NOXA) in nuclei of HT-29/B6 possessing inhibitory effects. |
Pubmed ID | 28149533 |
Year | 2017 |
Title | TFF3-dependent resistance of human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is mediated by miR-491-5p regulation of lncRNA PRINS. |
External Links
Links for PRINS | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |